News

Metal-on-Metal Hip Replacement Revision Rates Increased Since 2007: Study

Metal-on-metal hip implants have been alleged to cause metal particles to be released into the bloodstream and surrounding soft tissue. This can result in metallosis and often necessitate painful and more complicated revision surgery, in which the device is removed and replaced by an entirely new device. A new study published in the January 2018 issue of the Bone and Joint Journal indicates that revision rates increased significantly among recipients of metal-on-metal hip replacements after 2007. Involving over 24,500 patients who underwent hip replacement surgery between 2003 and 2012, the study concluded that device recipients from 2007 onward had a higher rate of revision at 5-years post-op compared to those who were implanted with the device prior to 2007.

If you or a loved one has experienced complications after receiving a metal-on-metal hip implant, please contact us by submitting the contact form or by calling us at 877-790-3588 for a confidential evaluation of your potential claim.

January Hearing to Address Future of Xarelto Claims

The Louisiana court overseeing thousands of Xarelto bleeding lawsuits has scheduled a hearing for January 30, 2018, following bellwether trials that concluded in December 2017. Two weeks prior to the hearing, the parties are instructed to submit joint briefs proposing how the federal litigation should proceed. Over 19,000 claims have been filed in this federal multidistrict litigation, alleging, among other things, that the pharmaceutical companies downplayed risks and inaccurately marketed Xarelto. The end of the month’s meeting will help determine the future of federally-filed Xarelto lawsuits.
 
If you or a loved one took Xarelto and suffered internal bleeding or a related medical condition, please contact our lawyers by calling us at 888-207-0382 for a confidential evaluation of your potential claim.

Bellwether Trial Cases to be Selected in Stryker LFIT V40 Litigation

The bellwether selection process in the Stryker LFIT V40 artificial hip litigation has been formally outlined, according to a December 8, 2017 order from the Massachusetts court. A total of 18 cases, similarly alleging problems with Styker’s LFIT V40 femoral head—a component used in several hip replacement systems—will be selected for inclusion in the bellwether discovery pool. Judge Talwani has ordered these cases to be selected by February 2, 2018. The first case is scheduled to go before a jury in September 2019.

The defective Stryker LFIT V40 femoral heads have caused catastrophic side-effects including separation of the femoral head from the hip stem, fracturing of the device, metallosis, tissue damage, and other complications that have led to painful hip revision surgery. If you or a loved one experienced complications after receiving a metal-on-metal hip implant, please contact us at 877-790-3588 for a confidential evaluation of your potential claim.

Johnson & Johnson Ordered to Pay $28 Million in Xarelto Lawsuit

On December 5, 2017, an Indiana couple won a lawsuit against Johnson & Johnson and Bayer over the companies’ failure to instruct on how to avoid internal bleeding risks of their blockbuster blood thinner, Xarelto. A Philadelphia jury handed down the $27.8 million verdict for plaintiffs suing over serious health complications alleged to be caused by Xarelto. This trial was the first of approximately 1,400 cases pending in the Pennsylvania court—a fraction of the over 18,500 consolidated cases pending in a multi-district litigation in Louisiana federal court alleging similar claims.

If you or a loved one took Xarelto and suffered internal bleeding or a related medical condition, please contact us by calling us at 888-207-0382 for a confidential evaluation of your potential claim.

$247 Million Verdict Against Johnson & Johnson for Pinnacle Hip Implants

In November 2017, it was announced that six patients implanted with Johnson & Johnson’s Pinnacle hip implant will share in a $247 million payday from the pharmaceutical company fueled by its faulty device. The patients—plaintiffs who filed lawsuits against the device manufacturer—alleged that the metal-on-metal design of the implant caused tissue death and bone erosion, among other complications. This is the third showdown Johnson & Johnson has lost thus far over allegations concerning its Pinnacle hip device. Prior outcomes include an initial $1 billion jury verdict announced in December 2016 and an initial $500 million jury award in March 2016.

If you or a loved one has experienced complications from a metal-on-metal hip implant, please contact us at (877) 790-3588 for a confidential evaluation of your potential claim.

Real Time Analytics